Patent: 10,300,185
✉ Email this page to a colleague
Summary for Patent: 10,300,185
| Title: | Guidable intravascular blood pump and related methods |
| Abstract: | An improved intravascular blood pump and related methods involving the broad inventive concept of equipping the intravascular blood pump with guiding features such that the intravascular blood pump can be selectively positioned at a predetermined location within the circulatory system of a patient. |
| Inventor(s): | Walid N. Aboul-Hosn, William R. Kanz, Bruce A. Baker |
| Assignee: | Maquet Cardiovascular LLC |
| Application Number: | US16/153,355 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,300,185
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Genentech, Inc. | XOLAIR | omalizumab | For Injection | 103976 | 20-Jun-03 | 10,300,185 | 2038-10-05 |
| Genentech, Inc. | XOLAIR | omalizumab | Injection | 103976 | 28-Sep-18 | 10,300,185 | 2038-10-05 |
| Genentech, Inc. | XOLAIR | omalizumab | Injection | 103976 | 17-Aug-23 | 10,300,185 | 2038-10-05 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,300,185
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Austria | E337818 | ⤷ Start Trial |
| Australia | 3298401 | ⤷ Start Trial |
| Australia | 3582100 | ⤷ Start Trial |
| Australia | 4189499 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
